Larson Financial Group’s NeoGenomics NEO Stock Holding History

Larson Financial Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$186	Sell	25 -338	-93%	-$3.56K	﹤0.01%	3462
2025 Q4	$4.27K	Buy	363 +219	+152%	+$2.36K	﹤0.01%	2520
2025 Q3	$1.11K	Buy	144 +133	+1,209%	+$932	﹤0.01%	2891
2025 Q2	$80	Sell	11 -69	-86%	-$557	﹤0.01%	3192
2025 Q1	$759	Buy	80 +65	+433%	+$812	﹤0.01%	2466
2024 Q4	$247	Hold	15	–	–	﹤0.01%	2384
2024 Q3	$221	Hold	15	–	–	﹤0.01%	2340
2024 Q2	$208	Buy	+15	New	+$213	﹤0.01%	2053

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Larson Financial Group's NEO Position: Q1 2026 in Review

Larson Financial Group reduced its NeoGenomics (NEO) stake by 93% in Q1 2026, selling an estimated $3.56K and leaving 25 shares worth $186. The position accounts for ﹤0.01% of the portfolio, ranked #3462.

Larson Financial Group first reported a position in NEO in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.27K in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Larson Financial Group held 25 shares of NeoGenomics worth $186 as of Q1 2026.
Larson Financial Group sold 338 NeoGenomics shares in Q1 2026, an estimated $3.56K.
NeoGenomics made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3462 holding.
Larson Financial Group first reported a position in NeoGenomics in Q2 2024 and has held it in 8 quarters since.
Larson Financial Group's NeoGenomics position peaked at $4.27K in Q4 2025.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.